The White Paper on Artificial Intelligence published on February 19th by the European Commission presents some important building block policy options. These enable a trustworthy and secure development of artificial intelligence in the EU, fully respecting the presiding values and the fundamental rights of its citizens. The enormous volume of data which has already been
At a time when the economy is hit hard, competition rules increasingly play a central role in guaranteeing a level playing field between businesses.In view of developments on national level and following EU practices in cooperation with the European Competition Network (ECN), the Hellenic Competition Commission issued a Press Release on March 7th 2020, indicating
As governments and businesses work intensively on mitigating the impact of the new COVID-19 pandemic, social distancing measures have led to an increase in remote working across all sectors. Although remote work, when such is possible, is a necessary precaution measure during the pandemic, it does create new legal challenges. Some of these challenges include:
1) What do we call Force Majeure? What are its implications for contracts? According to Greek law, the term “act of God, force majeure”, is characterized by any unpredictable and extraordinary event which man, in the natural course of things, cannot foresee and prevent by extreme diligence and the prudence of an average. For example,
In the midst of the COVID-19 coronavirus pandemic and in an effort to limit and delay its spread, many companies are already processing various, new to date for businesses, personal data categories, including special categories of personal data, such as health data . The key issue that arises, however, relates to the extent and nature
Main risks related to the use of Artificial Intelligence → fundamental rights, including personal data and privacy protection and non-discrimination Artificial Intelligence (AI) can perform many functions that previously could only be done by humans. As a result, citizens and legal entities will be increasingly subject to actions and decisions taken by or with
Our firm’s approach on Genomic research and data protection in view of the CRISPR technology. You may read our article below: https://lawgroup.gr/wp-content/uploads/2020/03/Healthcare-and-Life-Sciences-Law-Sept-2019.pdf “This article first appeared on the website of the Healthcare and Life Sciences Law Committee of the Legal Practice Division of the International Bar Association, and is reproduced by kind permission of the
legal breakthrough
Michalopoulou & Associates successfully represented a medical devices company on dispute arising from the enforcement of a monetary amount on behalf of EOPYY related to the reimbursement of specific expendable medical supplies (medical dressings). Our team successfully proved before the competent court that the enforced monetary amount did not include sufficient and unambiguous justification in
Artificial intelligence and the application of AI in modern life has brought ground-braking changes in modern life, while newest innovative technologies are yet to come. Indeed, AI is a collective expression of multiple sectors bringing together a series of technologies from machine learning systems, in which computers can function, develop and improve through experience, to
The digital single market is one of European Union’s most important achievement and its best offer in times of ever greater globalization. The aim of the DSM strategy is to create an area where businesses and consumers have unrestricted access to digital goods and services all over Europe, where the free flow of data creates
Ms Michalopoulou and Ms Chatziantoniou have contributed to this year’s edition on the compliance of pharmaceutical companies with the local and European legislation and in particular the current legislative framework in Greece for providing information prior authorization of a medicinal product, advertising to healthcare professionals (HCPs), gifts and hospitality, regarding transparency and disclosure status as
Ms. Michalopoulou participated in the 15th Panhellenic Congress of Nutrition – Dietetics & 4th Panhellenic Conference on Clinical Nutrition & Metabolism held on December 14th, 2019 at the Athens International Conference Center. The theme of her speech was: “Personalized Nutrition during which she analyzed how the current legal framework is shaped in the light of
TOP